Handelsavisen
prelaunch
Companies Healthcare 197A.T
19
197A.T Tokyo Stock Exchange Medical Equipment, Supplies & Distribution

197a.T

¥485,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
5,32 %
Op margin
44,3 %
ROE
36,3 %
Net margin
33,9 %
Debt / equity
0,83
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

197A.T is a Japanese medical equipment and supplies company that generates revenue primarily through the sale of healthcare products and services.

Business. 197A.T is a Japanese medical equipment and supplies company that generates revenue primarily through the sale of healthcare products and services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
HOLD2 analysts
0 buy1 hold1 sell
Avg 12m price target450,00

Analyst recommendations

2 analysts · consensus Hold
Buy0
Hold1
Sell1
12-month price target
450,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
2 analysts · indicative
Ownership
not yet wired
Profitability
36,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 197A.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 197A.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    197A.T is a Japanese medical equipment and supplies company that generates revenue primarily through the sale of healthcare products and services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    197A.T maintains a liquidity position with a current ratio of 1.62, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's free cash flow is negative at -872.97 million JPY, and capital expenditures are substantial at -5.12 billion JPY, suggesting significant reinvestment in operations. The debt-to-equity ratio of 0.83 indicates a moderate level of leverage, with long-term debt amounting to 14.42 billion JPY against total equity of 17.42 billion JPY.

    The company's profitability is strong, with a return on equity of 36.26% and a return on assets of 17.3%, both exceeding typical industry benchmarks for medical equipment and supplies firms. Operating income of 8.24 billion JPY and net income of 6.32 billion JPY reflect a healthy margin structure, although gross profit of 12.77 billion JPY suggests a relatively high cost of goods sold.

    197A.T's revenue is not segmented by geographic region or product line in the available data, but the company's exposure is likely concentrated in Japan given its domestic listing and the absence of international revenue breakdowns. This lack of diversification could pose a risk if domestic demand fluctuates or if regulatory changes impact the healthcare sector in Japan.

    The company's growth trajectory is not explicitly outlined in the available data, but the current revenue of 18.63 billion JPY and the substantial capital expenditures suggest a strategy of expansion or modernization. Analysts have provided a mean price target of 450.00 JPY, with a median of 450.00 JPY, indicating a generally stable outlook.

    Risk factors for 197A.T include a medium liquidity risk due to a negative net cash position after subtracting total debt, and a low dilution risk as indicated by the risk assessment. The company's capital structure and financial flexibility may be constrained by its high capital expenditures and negative free cash flow, which could limit its ability to invest in new opportunities or respond to market changes.

    Recent events and filings for 197A.T are not detailed in the available data, but the company's financial performance and analyst estimates suggest a stable but not particularly dynamic business environment. The absence of strong buy or buy recommendations from analysts indicates a cautious outlook, with one hold recommendation and no strong sell or sell recommendations.

    Key takeaways
    • 197A.T has a strong return on equity and assets, indicating efficient use of capital and assets.
    • The company's liquidity position is moderate, with a current ratio of 1.62 but negative free cash flow.
    • 197A.T's capital expenditures are substantial, suggesting a focus on expansion or modernization.
    • Analysts have a generally stable outlook for the company, with a mean price target of 450.00 JPY.
    • The company's risk profile is characterized by medium liquidity risk and low dilution risk.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥485,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥17.42B
    Net cash
    -¥5.16B
    Current ratio
    1.6
    Debt / equity
    0.8
    ROA
    17.3%
    ROE
    36.3%
    Cash conversion
    108.0%
    CapEx / revenue
    -27.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    53,84
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    2
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-04 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate53,84
    Revenueno estimateno estimate14,8B JPY
    Operating incomeno estimateno estimateno estimate
    Full-year consensus mean (period as reported by source) · consensus in JPY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution2 analysts
    Strong buy0
    Buy0
    Hold1
    Sell1
    Strong sell0
    12-month price target¥450,00 · Median ¥450,00
    Low ¥410,00High ¥490,00
    EPS surprise
    +15,3 %
    reported vs consensus · beat
    Revenue surprise
    +25,6 %
    reported vs consensus · beat

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low¥410,00
    Mean¥450,00
    Median¥450,00
    High¥490,00
    Spot¥485,00
    −7.2 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin44,2 %Best in class
    Net Margin33,9 %Best in class
    ROE36,3 %Best in class
    Capex / Rev-27,5 %Bottom quartile
    D/E0,83Bottom quartile
    Cash Conv1,08Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • 197A.T Market data — financials · 2026-05-26
    • Tauns Laboratories Inc Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    197A.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage